There have been several EV cargoes that can potentially be utilized as serum predictive biomarkers, including PIGR, CRP, FRIL, and fibrinogen, that predict CCA development in PSC patients before it is clinically evident [104]. The gene discussed is CRP; the disease is cholangiocarcinoma.